FDA warns J & J on insulin pumps

Share this article:

Johnson & Johnson could face penalties for not reporting incidents where insulin pumps have failed, the Food and Drug Administration has warned.

In a Dec. 27 letter to the company's Animas Corp. unit, the FDA says the company should have reported incidents where the device failure may have caused injury, including diabetic ketoacidosis. It also said Animas failed to create a system for making adequate medical device reports.

The letter, which was made public last week, followed a site visit in 2011. It warns “failure to promptly correct these violations may result in regulatory action being initiated by the FDA without further notice.”

Diabetes is among the top ten leading causes of death in the U.S. Insulin pumps deliver rapid- or short-acting insulin throughout the day via a catheter rather than require a person or caregiver to do periodic injections.



Share this article:

More in News

Assisted living communities continue to make a terrible first impression on prospective customers, university program finds

Assisted living communities continue to make a terrible ...

Assisted living communities consistently do not make a good first impression with prospective customers, and they haven't improved this skill set in the last decade, according to data from George ...

Latecomers to hospice frequently are male, have certain cancers, Penn researchers find

Men and patients with certain types of cancer are among those less likely to enroll in hospice, suggesting that healthcare providers should focus on presenting these groups with all their end-of-life care options, according to newly published findings.

Nursing homes should think twice before using a well-known tool for diagnosing ...

A familiar tool for diagnosing depression in dementia patients might not be very effective in the nursing home setting, according to findings recently published in The American Journal of Geriatric Psychiatry.